Diabetes Discourse

Informações:

Sinopsis

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

Episodios

  • Continuous Glucose Monitoring

    26/05/2009

    Guest: Chris Sadler, MA, PA-C, CDE Host: Steven Edelman, MD Technology continues to show great promise for people living with diabetes. One such technology is continuous glucose monitoring, a dynamic new technology with the potential to dramatically change the lives of type 1 diabetics and insulin-requiring type 2 diabetics. Join host Dr. Steven Edelman and his guest, certified diabetes educator and physician assistant Chris Sadler, as they discuss the benefits of continuous glucose monitoring.

  • Diabetic Retinopathy

    26/05/2009

    Host: Steven Edelman, MD Guest: Paul Tornambe, MD Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Join host Dr. Steven Edelman and his guest, ophthalmologist Dr. Paul Tornambe, an instructor in the departments of ophthalmology and family practice at the University of California, San Diego, as they discuss early diagnosis, tele-health and the exciting new VEGF inhibitors treatment of diabetic macular edema.

  • Toward Safe and Effective Insulin Initiation

    26/05/2009

    Guest: Ian Blumer, MD Host: Steven Edelman, MD Type 2 diabetes is a progressive disease and most patients will eventually need insulin to achieve euglycemia. Early and aggressive management to lower blood glucose reduces the risk of complications of the disease. It can be challenging for health care professionals to decide which treatment regimen is appropriate to manage a particular patient. Join host Dr. Steven Edelman and his guest, endocrinologist and medical advisor to the Charles H. Best Diabetes Centre in Ontario, Canada, Dr. Ian Blumer, as they discuss insulin initiation strategies.

página 11 de 11